Your browser doesn't support javascript.
loading
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.
Bocanegra, Ana; Fernández-Hinojal, Gonzalo; Ajona, Daniel; Blanco, Ester; Zuazo, Miren; Garnica, Maider; Chocarro, Luisa; Alfaro-Arnedo, Elvira; Piñeiro-Hermida, Sergio; Morente, Pilar; Fernández, Leticia; Remirez, Ana; Echaide, Miriam; Martinez-Aguillo, Maite; Morilla, Idoia; Tavira, Beatriz; Roncero, Alejandra; Gotera, Carolina; Ventura, Alfonso; Recalde, Nerea; Pichel, José G; Lasarte, Juan José; Montuenga, Luis; Vera, Ruth; Pio, Ruben; Escors, David; Kochan, Grazyna.
Afiliación
  • Bocanegra A; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Fernández-Hinojal G; Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.
  • Ajona D; Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
  • Blanco E; CIBERONC, Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
  • Zuazo M; Department of Biochemistry and Genetics, School of Sciences, University of Navarra-IdISNA, Pamplona, Spain.
  • Garnica M; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Chocarro L; Program in Gene Therapy and Regulation of Gene Expression, CIMA-University of Navarra-IdISNA, Pamplona, Spain.
  • Alfaro-Arnedo E; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Piñeiro-Hermida S; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Morente P; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Fernández L; Lung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR), Fundación Rioja Salud, Logroño, Spain.
  • Remirez A; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Echaide M; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Martinez-Aguillo M; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Morilla I; Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
  • Tavira B; Oncoimmunology Group, Navarrabiomed, Hospital Universitario de Navarra, Universidad Publica de Navarra (UPNA), IdISNA, Pamplona, Spain.
  • Roncero A; Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Spain.
  • Gotera C; Department of Oncology, Hospital Universitario de Navarra-IdISNA, Pamplona, Spain.
  • Ventura A; Program in Solid Tumors, CIMA-University of Navarre-IdISNA, Pamplona, Spain.
  • Recalde N; Cancer Center University of Navarra (CCUN), Pamplona, Spain.
  • Pichel JG; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra-IdISNA, Pamplona, Spain.
  • Lasarte JJ; Pathological Anatomy Service, Hospital Universitario San Pedro, Rioja Salud, Logroño, Spain.
  • Montuenga L; Pneumology Service, Rioja Salud, Logroño, Spain.
  • Vera R; Fundación Jiménez Díaz, Madrid, Spain.
  • Pio R; Centro de Salud Salazar-Ezcároz, Navarra, Spain.
  • Escors D; Centro de Salud Salazar-Ezcároz, Navarra, Spain.
  • Kochan G; Lung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR), Fundación Rioja Salud, Logroño, Spain.
EMBO Rep ; 24(8): e55884, 2023 08 03.
Article en En | MEDLINE | ID: mdl-37366231

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article